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Abstract
Background: Human respiratory syncytial virus (HRSV) is a leading viral etiologic agent of pediatric lower respiratory
infections, including bronchiolitis and pneumonia. Two antigenic subgroups, HRSV-A and B, each contain several
genotypes. While viral load may vary among HRSV genotypes and affect the clinical course of disease, data are scarce
regarding the actual differences among genotypes. Therefore, this study estimated and compared viral load among
NA1 and ON1 genotypes of HRSV-A and BA9 of HRSV-B. ON1 is a newly emerged genotype with a 72-nucleotide
duplication in the G gene as observed previously with BA genotypes in HRSV-B.
Findings: Children <5 years of age with an initial diagnosis of severe or very severe pneumonia at a hospital in the
Philippines from September 2012 to December 2013 were enrolled. HRSV genotypes were determined and the viral
load measured from nasopharyngeal swabs (NPS). The viral load of HRSV genotype NA1 were significantly higher than
those of ON1 and BA9. Regression analysis showed that both genotype NA1 and younger age were significantly
associated with high HRSV viral load.
Conclusions: The viral load of NA1 was higher than that of ON1 and BA9 in NPS samples. HRSV genotypes may be
associated with HRSV viral load. The reasons and clinical impacts of these differences in viral load among HRSV
genotypes require further evaluation.
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Findings
Human respiratory syncytial virus (HRSV) is a major
etiologic agent of lower respiratory tract infections, in-
cluding bronchiolitis and pneumonia, and a leading
cause of hospitalizations among infants in both develop-
ing and developed countries [1]. Two subgroups, HRSV-
A and HRSV-B, have been described. A total of 11
HRSV-A genotypes have been identified, including GA1
to GA7 [2], SAA1 [3], NA1 and NA2 [4], and, most re-
cently, ON1, which has a 72-nucleotide duplication in
the G gene [5]. A total of 19 HRSV-B genotypes have
been reported, including GB1 to GB4 [2], SAB1 to SAB3
[3], and BA, with a 60-nucleotide duplication in the G
gene, which is subdivided into BA1 to BA12 [6–9]. The
newly-emerged BA genotypes have replaced the previous
genotypes [10]; similarly, ON1, derived from NA1 of
HRSV-A, has been recently reported in many regions
worldwide [11–13]. Both BA and ON1 have nucleotide
duplications in the hypervariable region of the G gene.
However, the effect of these duplications on the spread
of these genotypes remains unknown. Although, viral
load is an important factor in HRSV disease and severity
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HRSV viral load among different genotypes. We there-
fore investigated HRSV viral load among three genotypes
identified in hospitalized pediatric patients.
A case series study was conducted from September
2012 to August 2013 in the Biliran Provincial Hospital, a
referral hospital on Biliran Island [15] in the Philippines.
Children aged <5 years admitted with an initial diagnosis
of severe or very severe pneumonia based on Integrated
Management of Childhood Illness criteria (IMCI) [16]
were asked participation into the study and written par-
ental consent was obtained for each participant. Severe
pneumonia were defined as cases with cough and/or
difficulty of breathing accompanied by chest indrawing
and/or one or more danger signs including inability to
drink, convulsion or lethargic/asleep. Local medical
staffs were trained with a standardized protocol for
nasopharyngeal swab (NPS) samples through the study
period. Samples were taken using EX-swab 002 (DENKA
SEIKEN Tokyo, Japan), stirred in 3 ml viral transport
medium, which consists of Hanks BSS (Balanced salt so-
lution), 0.25 % gelatin, 0.035 % sodium bicarbonate,
Streptomycin (500 μg/mL) and Penicillin (500 U/mL)
and Amphotericin B (250 μg/mL) and kept at 0–4 °C.
Viral RNA was extracted using the QIAamp MinElute
Virus Spin Kit (QIAGEN, Hilden, Germany) and cDNA
was synthesized using Moloney murine leukemia virus
reverse transcriptase and random primers (Thermo Sci-
entific, Boston, MA, USA).
The first real-time polymerase chain reaction (PCR)
for screening of HRSV was performed using an Applied
Biosystems StepOnePlus system (Applied Biosystems,
Foster City, CA, USA) as previously described, with
some modifications [17] in Research Institute for Trop-
ical Medicine (RITM), Metro Manila. The region of the
N gene targeted by the real-time PCR is highly con-
served among subgroups and genotypes. The detection
limit of the assay was 100 copies for all genotypes.
The positive cDNA samples were shipped from RITM
to laboratory at Tohoku University and viral load was
defined as viral RNA copy number estimated from mean
threshold cycle (Ct) values in duplicated samples ob-
tained from the second real-time PCR with synthesized
viral genomic RNA standard samples for each genotype
(N gene, 658 nucleotides). For subgrouping and genotyp-
ing, the C-terminus region of the G gene was amplified
and sequenced as previously described [18].
Patient characteristics, clinical symptoms, elapsed time
between illness onset and specimen collection, viral co-
infection (influenza virus, human rhinovirus/enterovirus,
human metapneumovirus, and human parainfluenza
virus) and viral load (Log10 RNA copies/μL) were com-
pared among HRSV genotypes using chi-square and
Kruskal-Wallis tests and one-way analysis of variance
(ANOVA). The beta coefficients for associations between
viral load and genotypes or other factors were adjusted
by generalized linear regression. Statistical analysis was
performed using IBM SPSS Statistics for Windows, ver-
sion 20 (IBM Corp, Armonk, NY, USA) and a P value of
< 0.05 was considered statistically significant.
A total of 440 clinical samples were collected. Of
these, 179 (40.7 %) were positive for HRSV by the first
run of the real-time PCR. Viral load of the 33 samples
were not included in the analysis due to not having
enough volume for the replication (n = 29) or negative
results in the second run (n = 4), therefore, duplicated Ct
values were obtained from 146 (81.5 %) of HRSV posi-
tive samples. Moreover, six samples were excluded due
to discordant results in two replicates (n = 4) and failure
in subgrouping (n = 2). A total of 140 samples were
genotyped and the numbers of NA1, ON1, and BA9
genotypes were 17 (12.1 %), 51 (36.4 %), and 71
(50.7 %), respectively. One sample (0.7 %) identified
as genotype GB2 was excluded from further analysis.
Genotype ON1 was first detected in December in the
study population. Background characteristics and
symptoms of the 139 HRSV positive patients included
in the analyses are shown in Table 1. Their median
age was 9 months old (interquartile range, 3–17 months)
and 60.4 % were male. The mean interval between
illness onset and specimen collection was 4 days. No
congenital heart disease or chronic lung disease were
reported.
Viral loads were higher in patients with genotype NA1
than in those with genotypes ON1 and BA9 (P = 0.0002,
Table 1). Multiple regression analysis showed that youn-
ger age at admission and genotype NA1 were associated
with higher HRSV viral load (Table 2). Because the NA1
viral load was also higher in infants less than 6 months
of age (P = 0.032, Table 1), with possibly their first HRSV
infections, the immunological effects of prior infection
in this age group was minimal. Since genotype NA1 had
been a major genotype [18] and ON1 newly introduced
in this area during the study period, the effect of ma-
ternal immunity does not explain the low viral load
of ON1. Therefore, the difference of viral loads
among genotypes was not likely due to differences in
preexisting immunity at enrollment. In addition, pre-
vious studies have shown that neutralizing antibody
titer at disease onset is not associated with HRSV
viral load [19]. HRSV viral load showed a strong posi-
tive correlation with younger age at admission. Young
infants undergo significant anatomic and immuno-
logical changes during their development, which may
affect HRSV replication patterns in different pediatric
age groups.
Genetic differences among genotypes may explain the
differences in viral load. ON1 has a 72-nucleotide inser-
tion in the G gene [5]. This insertion is absent in the
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NA1 genotype and is the largest insertion described to
date in this genus, which may affect the viral structure
and pathogenesis. BA9, also characterized by an inser-
tion in the G gene, also showed significantly lower viral
load compared to NA1. The G protein is one of the
major HRSV protective antigens and has significant roles
in cell attachment [20], cell fusion [21], and immune re-
sponse [22]. Insertions and duplications in the G gene
may have affected the efficiency of HRSV replication in
the newly emerged ON1 and BA genotypes. Detailed
molecular analysis of the G protein gene sequence of
several HRSV strains commonly reveal multiple short se-
quence repeats. The earlier report in HRSV-B of the 60-
nucleotide duplication (the BA genotypes) had shown an
exceptional example of repeated sequence in the G pro-
tein, which emerged and replaced previous genotypes
within HRSV-B [10]. Further studies are needed to bet-
ter understand why viral load differs among genotypes
Table 1 Characteristics of 139 hospitalized patients due to severe acute respiratory infection by HRSV genotypes
HRSV genotype NA1 ON1 BA9 P value
n = 17 n = 51 n = 71
Age in months, median [IQR] 10 [3–19] 6 [3–11] 11 [5–19] 0.026*
Males (%) 10 (58.8) 33 (64.7) 41 (57.7) 0.733**
Days between illness onset and specimen collection, median [IQR] 4 [3–5] 5 [4–7] 4 [3–7] 0.074*
Symptoms (%)
Fever 13 (76.5) 39 (76.5) 61 (85.9) 0.361**
Cough 17 (100.0) 51 (100.0) 71 (100.0) -
Chest indrawing 17 (100.0) 51 (100.0) 71 (100.0) -
Difficulty of breathing 12 (70.6) 41 (80.4) 50 (70.4) 0.436**
Inability of drink 0 (0.0) 1 (2.0) 5 (7.0) 0.255**
Neurological signs 0 (0.0) 5 (9.8) 5 (7.4) 0.398**
Peripheral oxygen saturation < 90 % (%) 1 (5.9) 6 (11.8) 11 (15.5) 0.542**
Viral coinfection (%) 0 (0.0) 7 (13.7) 4 (8.4) 0.114**
Viral load (Log10 RNA copies/μL), median [IQR]
All ages 6.5 [5.8–6.8] 5.4 [4.6–6.2] 5.4 [4.8–6.1] <0.001***
< 6 months (n = 6) (n = 27) (n = 21)
6.6 [6.2–7.2] 5.7 [4.7–6.4] 5.8 [5.2–6.2] 0.032*
HRSV: Human Respiratory Syncytial Virus, Neurological sign: history of convulsion or lethargic/asleep
*Kruskal-Wallis test, **chi-square test, ***one-way ANOVA
IQR: 25th and 75th Interquartile range, One patient positive for genotype GB2 was excluded from this analysis
Table 2 Distribution and adjusted coefficients of viral and patient factors for HRSV viral load
Variables n β (95 % CI) P value
Age (months) < 6 54 Ref. -
6–11.9 32 −0.21 (−0.57, 0.15) 0.264
≥ 12 53 −0.55 (−0.92, −0.18) 0.004
Sex Female 55 Ref. -
Male 84 0.28 (−0.02, 0.58) 0.072
Days between illness onset and
specimen collection
< 4 45 Ref. -
≥ 4 94 0.15 (−0.16, 0.46) 0.347
Genotype NA1 17 Ref. -
ON1 51 −1.13 (−1.53, −0.73) < 0.001
BA9 71 −0.92 (−1.27, −0.56) < 0.001
Viral coinfection No 128 Ref. -
Yes 11 −0.19 (−0.82, 0.44) 0.552
HRSV human respiratory syncytial virus, β: Coefficients for viral load (Log10 RNA copies/μL) were adjusted for the variables each other by generalized linear model.
One patient positive for genotype GB2 was excluded from this analysis
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as well as the impact of new insertions in the G gene on
HRSV pathogenesis.
Limitation of our observation is the small number of
patients in NA1 group and NPS sampling by different
study personnel, which may have had inter- sampling
variation. Also viral load in NPS may not enhance the
severity of lower respiratory infection. Others factors
that may influence HRSV viral load such as, prematurity,
breast feeding status and use of steroids or other im-
munosuppressive medication were not assessed in this
study.
In the present study, age and viral genotypes were host
and viral factors that independently predicted HRSV
viral load. Age is a well-known predictor of HRSV
disease severity [1] and is also associated with HRSV
viral load. Although other studies using molecular
techniques did not observe differences in viral load
between HRSV subgroups [23, 24], differences in sam-
ple size, sample collection, or circulating genotypes
during their study periods could explain this differ-
ence in findings. Our findings suggest the critical
need for further studies to investigate potential differ-
ences in viral load among genotypes and their associ-
ation with disease severity.
Appendix
Abbreviations
Ct, cycle threshold; HRSV, human respiratory syncytial virus; NPS,
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